Le Lézard
Classified in: Health

PANTHERx Specialty Pharmacy® Awarded Fourth Accreditation from VIPPS


PITTSBURGH, Feb. 19, 2018 /PRNewswire/ -- PANTHERx Specialty Pharmacy®, THE Rare Disease Specialty Pharmacy®, announced today that it has received the Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association of Boards of Pharmacy (NABP), an association that works to ensure higher levels of public health and safety by administering pharmacist assessment programs, pharmacists license transfers, and pharmacy accreditations.

PANTHERx Specialty is nationally recognized as THE Rare Disease Specialty Pharmacy (R), assisting in successful launch of medications targeted to rare and orphan diseases.

The VIPPS accreditation seeks to separate safe pharmacy websites from the ever-increasing number of illegal pharmacy websites. To achieve this accreditation, PANTHERx Specialty Pharmacy® had to demonstrate that it follows and satisfies the licensing and inspection requirements in each state that the company practices pharmacy, and that www.PantherSpecialty.com meets criteria outlined by the National Association of Boards of Pharmacy.

Receipt of the VIPPS accreditation from the NABP demonstrates a commitment by PANTHERx Specialty Pharmacy® to providing an online presence that reflects the uncompromising quality of its internal standards and practices. Patients searching for a pharmacy online should not have to question the validity and safety of a company, and the VIPPS accreditation helps provide a safer community to connect patients with pharmacy.

"PANTHERx is committed to superior quality in patient and partner service," states PANTHERx Specialty Pharmacy® Chairman and CEO Dr. Gordon J. Vanscoy.  "Achieving our fourth accreditation, by VIPPS, is a validation of our focus, process and results. We are proud to make this announcement today which is a testament of PANTHERx excellence in every aspect of our business and the care we deliver."

About NABP
The National Association of Boards of Pharmacy is an independent, international, and impartial association founded in 1904 for the purpose of protecting the public health. NABP's member boards of pharmacy are grouped into eight districts that include all 50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, Australia, Bahamas, and 10 Canadian provinces. The NABP offers pharmacy accreditations, pharmacist license transfers, and pharmacist competence assessment programs to help better public health and safety. For more information, visit https://nabp.pharmacy.

About PANTHERx Specialty Pharmacy
PANTHERx Specialty Pharmacy®, THE Rare Disease Specialty Pharmacy®, is a national, quad-accredited, specialty pharmacy headquartered in Pittsburgh, Pennsylvania. PANTHERx Specialty's mission is to transform lives by delivering medical breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. PANTHERx works daily to Reinvent Specialty, Revolutionize Pharmacy, and Redefine Care®, by developing focused solutions, bold innovations, and novel clinical services associated with life-transforming therapies.

For more information, please visit www.pantherspecialty.com or www.nabp.pharmacy/programs/vipps.

Contact
Bridget Regan
1-855-726-8479
[email protected]  

SOURCE PANTHERx Specialty Pharmacy


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: